Status:
WITHDRAWN
Mean Arterial Pressure (MAP) and Renal Perfusion: Evaluation of Critically Ill Patients With Normal Creatinine or Reduced Renal Function
Lead Sponsor:
University Hospital, Ghent
Conditions:
Kidney Failure, Acute
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the renal perfusion depending on the MAP.
Eligibility Criteria
Inclusion
- Over 18 years old
- Intensive care patient
- Treated with vasopressor
- Given informed consent
- Arterial infusion
- A bladder catheter
Exclusion
- Anamneses of hypertension
- Neurological trauma
- Acute renal insufficiency other than prerenal or acute tubular necrosis etiology
- Hepatorenal syndrome
- Treated with diuretics
- Mechanical ventilation and unstable
Key Trial Info
Start Date :
February 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2003
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00117416
Start Date
February 1 2003
End Date
February 1 2003
Last Update
December 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Ghent
Ghent, Belgium, 9000